FDA Inspection
Joseph S. Gimbel, MDJoseph S. Gimbel, MD – FDA Inspection, Aug 20, 2012
Record Details
This FDA Inspection record concerns Joseph S. Gimbel, MD, with an inspection on August 20, 2012, issued by the Center for Drug Evaluation and Research, covering drugs.
- Company
- Joseph S. Gimbel, MD
- Inspection Date
- August 20, 2012
- Product Type
- Drugs
View Company Profile
ID · 18e845f1-718f-42ca-b4de-108b9f1ae8d8
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 796271
- FDA center
- Human Drugs
- Project area
- Bioresearch Monitoring
FDA Citations
1- 21 CFR 312.50Ensuring compliance with plan and protocol
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Joseph S. Gimbel, MD
5| Date | Classification | Office | Project area |
|---|---|---|---|
| October 10, 2025 | Not classified | Denver District Office | |
| October 2, 2019 | NAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
| April 12, 2018 | NAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
| June 9, 2015 | NAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
| January 30, 2014 | VAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
Other documents for Joseph S. Gimbel, MD
- FDA Inspection 1287792 - 2025-10-10
- FDA Inspection 1106749 - 2019-10-02
- FDA Inspection 1048846 - 2018-04-12
- FDA Inspection 931953 - 2015-06-09
- FDA Inspection 865172 - 2014-01-30
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.